New York A10748 mandates coverage for treatments to slow Alzheimer's disease and related dementias.

New York A10748 amends the insurance law to require coverage for all medically necessary diagnostic testing and FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's disease and related dementias. This coverage applies to all group or blanket policies providing medical, major medical, or similar comprehensive-type coverage. The bill also mandates coverage for these treatments under medical expense indemnity corporations, hospital service corporations, and health service corporations.

New York A10748 mandates coverage for treatments to slow Alzheimer's disease and related dementias.

New York A10748 amends the insurance law to require coverage for all medically necessary diagnostic testing and FDA-approved treatments or medications prescribed to slow the progression of Alzheimer's disease and related dementias. This coverage applies to all group or blanket policies providing medical, major medical, or similar comprehensive-type coverage. The bill also mandates coverage for these treatments under medical expense indemnity corporations, hospital service corporations, and health service corporations.